Midas Management’s Biogen BIIB Stock Holding History

Midas Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$327K	Hold	1,400	–	–	0.14%	99
2019 Q1	$331K	Hold	1,400	–	–	0.14%	107
2018 Q4	$421K	Hold	1,400	–	–	0.2%	106
2018 Q3	$495K	Hold	1,400	–	–	0.22%	103
2018 Q2	$406K	Hold	1,400	–	–	0.19%	101
2018 Q1	$383K	Hold	1,400	–	–	0.18%	101
2017 Q4	$446K	Hold	1,400	–	–	0.18%	115
2017 Q3	$439K	Hold	1,400	–	–	0.23%	97
2017 Q2	$380K	Hold	1,400	–	–	0.2%	105
2017 Q1	$383K	Hold	1,400	–	–	0.2%	111
2016 Q4	$397K	Hold	1,400	–	–	0.19%	139
2016 Q3	$439K	Buy	+1,400	New	+$415K	0.27%	115

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Midas Management's BIIB Position: Q2 2019 in Review

Midas Management held its Biogen (BIIB) position steady in Q2 2019 at 1,400 shares worth $327K. The position accounts for 0.14% of the portfolio, ranked #99.

Midas Management first reported a position in BIIB in Q3 2016 and has held it in 12 quarters since. The position peaked at $495K in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

Midas Management held 1,400 shares of Biogen worth $327K as of Q2 2019.
Midas Management left its Biogen share count unchanged in Q2 2019.
Biogen made up 0.14% of Midas Management's portfolio in Q2 2019, its #99 holding.
Midas Management first reported a position in Biogen in Q3 2016 and has held it in 12 quarters since.
Midas Management's Biogen position peaked at $495K in Q3 2018.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Midas Management's 13F filing for Q2 2019, filed 9 Jul 2019.